55 results
Page 2 of 3
8-K
EX-99.2
8cjac85350rsbd
8 Apr 22
C4 Therapeutics Presents Clinical Data from Cohort A of the Ongoing Phase 1/2 Clinical Trial of CFT7455, a Novel IKZF1/3 Degrader
1:21pm
8-K
EX-99.1
ojp0pnhm
8 Apr 22
C4 Therapeutics Presents Clinical Data from Cohort A of the Ongoing Phase 1/2 Clinical Trial of CFT7455, a Novel IKZF1/3 Degrader
1:21pm
8-K
EX-10.1
cwcq0ctc n7o08e0vh
30 Nov 21
Entry into a Material Definitive Agreement
4:18pm
S-3ASR
3fbdan3
10 Nov 21
Automatic shelf registration
5:19pm
S-3ASR
EX-1.2
p5kqinweyatrw ajb
10 Nov 21
Automatic shelf registration
5:19pm
424B4
mijc5b hr1hn7zyl
21 Jun 21
Prospectus supplement with pricing info
8:08am
DRS
gmwo02yg4sg 0f6i5
19 May 21
Draft registration statement
12:00am
DEF 14A
15bd6e kglat0j
26 Apr 21
Definitive proxy
4:22pm
10-K
vtd2363k 1k6da
11 Mar 21
Annual report
4:19pm
10-Q
d51h4iwr 27xe
12 Nov 20
Quarterly report
4:28pm
424B4
50mc3v3k xl8s4eyrahw
2 Oct 20
Prospectus supplement with pricing info
5:10pm